BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25414788)

  • 1. The
    Oun R; Floriano RS; Isaacs L; Rowan EG; Wheate NJ
    Toxicol Res (Camb); 2014 Nov; 3(6):447-455. PubMed ID: 25414788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbit[n]uril binding of platinum anticancer complexes.
    Wheate NJ; Buck DP; Day AI; Collins JG
    Dalton Trans; 2006 Jan; (3):451-8. PubMed ID: 16395444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cucurbit[7]uril encapsulated cisplatin overcomes cisplatin resistance via a pharmacokinetic effect.
    Plumb JA; Venugopal B; Oun R; Gomez-Roman N; Kawazoe Y; Venkataramanan NS; Wheate NJ
    Metallomics; 2012 Jun; 4(6):561-7. PubMed ID: 22610518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are cucurbiturils better drug carriers for bent metallocenes? Insights from theory.
    Senthilnathan D; Solomon RV; Kiruthika S; Venuvanalingam P; Sundararajan M
    J Biol Inorg Chem; 2018 May; 23(3):413-423. PubMed ID: 29502216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cisplatin slow-release hydrogel drug delivery system based on a formulation of the macrocycle cucurbit[7]uril, gelatin and polyvinyl alcohol.
    Oun R; Plumb JA; Wheate NJ
    J Inorg Biochem; 2014 May; 134():100-5. PubMed ID: 24595010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral supramolecular switches based on (R)-binaphthalene-bipyridinium guests and cucurbituril hosts.
    Gao C; Silvi S; Ma X; Tian H; Credi A; Venturi M
    Chemistry; 2012 Dec; 18(52):16911-21. PubMed ID: 23136090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cucurbituril binding of trans-[{PtCl(NH3)2}2(micro-NH2(CH2)8NH2)]2+ and the effect on the reaction with cysteine.
    Bali MS; Buck DP; Coe AJ; Day AI; Collins JG
    Dalton Trans; 2006 Dec; (45):5337-44. PubMed ID: 17102858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical cream-based dosage forms of the macrocyclic drug delivery vehicle cucurbit[6]uril.
    Seif M; Impelido ML; Apps MG; Wheate NJ
    PLoS One; 2014; 9(1):e85361. PubMed ID: 24454850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Immunosafety of Cucurbit[n]uril In Vivo.
    Pashkina E; Aktanova A; Boeva O; Bykova M; Gavrilova E; Goiman E; Kovalenko E; Saleh N; Grishina L; Kozlov V
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38276497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile synthesis of cucurbit[n]uril derivatives via direct functionalization: expanding utilization of cucurbit[n]uril.
    Jon SY; Selvapalam N; Oh DH; Kang JK; Kim SY; Jeon YJ; Lee JW; Kim K
    J Am Chem Soc; 2003 Aug; 125(34):10186-7. PubMed ID: 12926937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complexation of ferrocene derivatives by the cucurbit[7]uril host: a comparative study of the cucurbituril and cyclodextrin host families.
    Jeon WS; Moon K; Park SH; Chun H; Ko YH; Lee JY; Lee ES; Samal S; Selvapalam N; Rekharsky MV; Sindelar V; Sobransingh D; Inoue Y; Kaifer AE; Kim K
    J Am Chem Soc; 2005 Sep; 127(37):12984-9. PubMed ID: 16159293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formation and stabilization of silver nanoparticles with cucurbit[n]urils (n = 5-8) and cucurbituril-based pseudorotaxanes in aqueous medium.
    Lu X; Masson E
    Langmuir; 2011 Mar; 27(6):3051-8. PubMed ID: 21322592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supramolecular modification of ion chemistry: modulation of peptide charge state and dissociation behavior through complexation with cucurbit[n]uril (n = 5, 6) or alpha-cyclodextrin.
    Zhang H; Grabenauer M; Bowers MT; Dearden DV
    J Phys Chem A; 2009 Feb; 113(8):1508-17. PubMed ID: 19191519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a fluorescent dye for indicator displacement from cucurbiturils: a macrocycle-responsive fluorescent switch operating through a pKa shift.
    Praetorius A; Bailey DM; Schwarzlose T; Nau WM
    Org Lett; 2008 Sep; 10(18):4089-92. PubMed ID: 18722450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study.
    Uzunova VD; Cullinane C; Brix K; Nau WM; Day AI
    Org Biomol Chem; 2010 May; 8(9):2037-42. PubMed ID: 20401379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbituril-Oriented Nanoplatforms in Biomedical Applications.
    Cheng G; Luo J; Liu Y; Chen X; Wu Z; Chen T
    ACS Appl Bio Mater; 2020 Dec; 3(12):8211-8240. PubMed ID: 35019600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A chemical preformulation study of a host-guest complex of cucurbit[7]uril and a multinuclear platinum agent for enhanced anticancer drug delivery.
    Kennedy AR; Florence AJ; McInnes FJ; Wheate NJ
    Dalton Trans; 2009 Oct; (37):7695-700. PubMed ID: 19759943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cucurbituril-mediated supramolecular acid catalysis.
    Klöck C; Dsouza RN; Nau WM
    Org Lett; 2009 Jun; 11(12):2595-8. PubMed ID: 19462966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Switching in Confined Spaces: Effects of Encapsulating the DHA/VHF Photo-Switch in Cucurbiturils.
    Petersen MÅ; Rasmussen B; Andersen NN; Sauer SPA; Nielsen MB; Beeren SR; Pittelkow M
    Chemistry; 2017 Dec; 23(67):17010-17016. PubMed ID: 28922509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Cucurbit[7]uril on the Antitumor and Immunomodulating Properties of Oxaliplatin and Carboplatin.
    Pashkina E; Aktanova A; Mirzaeva I; Kovalenko E; Andrienko I; Knauer N; Pronkina N; Kozlov V
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.